CYNTHIA FIACCO: Open Payments
NPI 1063612661 · CAMARILLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 13 payments from 8 companies in 2025. Trend: 2023 $606 · 2024 $1,120 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $174 |
| Amgen Inc. | 3 | $158 |
| Neurocrine BioSciences, Inc. | 1 | $137 |
| Ardelyx, Inc. | 1 | $130 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $121 |
| ABBVIE INC. | 1 | $105 |
| GlaxoSmithKline, LLC. | 3 | $61 |
Products named: INGREZZA, IBSRELA, BREZTRI, NUPLAZID, KRYSTEXXA, CREON, BENLYSTA, EVENITY.
Industry payments across CA — which companies pay providers there.
